Revvity ROA 2010-2025 | RVTY

Current and historical return on assets (ROA) values for Revvity (RVTY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Revvity ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $0.29B $12.36B 2.25%
2024-12-31 $0.27B $12.39B 2.08%
2024-09-30 $0.25B $12.77B 1.91%
2024-06-30 $0.17B $13.43B 1.26%
2024-03-31 $0.15B $13.43B 1.10%
2023-12-31 $0.69B $13.57B 4.96%
2023-09-30 $0.74B $13.42B 5.26%
2023-06-30 $0.82B $14.22B 5.76%
2023-03-31 $0.96B $14.64B 6.77%
2022-12-31 $0.57B $14.13B 3.99%
2022-09-30 $0.63B $13.82B 4.36%
2022-06-30 $0.67B $14.19B 4.57%
2022-03-31 $0.74B $14.85B 5.54%
2021-12-31 $0.94B $15.00B 7.96%
2021-09-30 $1.13B $14.90B 11.23%
2021-06-30 $1.18B $8.74B 14.63%
2021-03-31 $1.07B $8.76B 14.20%
2020-12-31 $0.73B $7.96B 10.46%
2020-09-30 $0.41B $6.87B 6.25%
2020-06-30 $0.30B $6.64B 4.53%
2020-03-31 $0.23B $6.38B 3.52%
2019-12-31 $0.23B $6.54B 3.57%
2019-09-30 $0.23B $6.49B 3.75%
2019-06-30 $0.25B $6.40B 4.14%
2019-03-31 $0.25B $6.09B 4.14%
2018-12-31 $0.24B $5.98B 3.98%
2018-09-30 $0.13B $5.86B 2.10%
2018-06-30 $0.14B $5.96B 2.44%
2018-03-31 $0.28B $6.13B 5.19%
2017-12-31 $0.29B $6.09B 5.93%
2017-09-30 $0.40B $4.74B 8.89%
2017-06-30 $0.37B $4.61B 8.35%
2017-03-31 $0.23B $4.34B 5.28%
2016-12-31 $0.23B $4.28B 5.51%
2016-09-30 $0.24B $4.31B 5.62%
2016-06-30 $0.23B $4.19B 5.64%
2016-03-31 $0.22B $4.21B 5.31%
2015-12-31 $0.21B $4.17B 5.20%
2015-09-30 $0.18B $4.03B 4.30%
2015-06-30 $0.16B $4.08B 4.02%
2015-03-31 $0.16B $4.03B 4.08%
2014-12-31 $0.16B $4.13B 3.94%
2014-09-30 $0.19B $3.89B 4.90%
2014-06-30 $0.19B $3.94B 4.86%
2014-03-31 $0.17B $3.97B 4.34%
2013-12-31 $0.17B $3.95B 4.33%
2013-09-30 $0.08B $3.85B 2.19%
2013-06-30 $0.07B $3.81B 1.92%
2013-03-31 $0.08B $3.81B 2.08%
2012-12-31 $0.07B $3.90B 1.84%
2012-09-30 $0.00B $3.89B 0.08%
2012-06-30 $0.01B $3.80B 0.27%
2012-03-31 $0.01B $3.86B 0.16%
2011-12-31 $0.01B $3.86B 0.23%
2011-09-30 $0.39B $3.40B 11.49%
2011-06-30 $0.36B $3.60B 10.90%
2011-03-31 $0.39B $3.31B 12.15%
2010-12-31 $0.39B $3.21B 12.38%
2010-09-30 $0.13B $3.25B 4.20%
2010-06-30 $0.13B $3.15B 4.30%
2010-03-31 $0.10B $3.03B 3.18%
2009-12-31 $0.08B $3.06B 2.78%
Sector Industry Market Cap Revenue
Medical Medical Services $11.192B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.515B 26.35
CVS Health (CVS) United States $84.516B 10.51
Elevance Health (ELV) United States $84.143B 10.86
Cencora (COR) United States $56.815B 19.77
Natera (NTRA) United States $23.263B 0.00
DiDi Global (DIDIY) China $22.732B 24.15
Labcorp Holdings (LH) United States $21.849B 17.72
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.354B 0.00
CochLear (CHEOY) Australia $12.742B 0.00
Solventum (SOLV) United States $12.673B 13.42
ICON (ICLR) Ireland $11.895B 11.06
Viatris (VTRS) United States $10.387B 3.57
Avantor (AVTR) United States $9.152B 13.30
Medpace Holdings (MEDP) United States $8.871B 23.56
HealthEquity (HQY) United States $8.752B 38.34
Sonic Healthcare (SKHHY) Australia $8.201B 0.00
Charles River Laboratories (CRL) United States $7.239B 14.19
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.245B 25.00
BrightSpring Health Services (BTSG) United States $4.003B 36.73
Sotera Health (SHC) United States $3.148B 17.89
Alignment Healthcare (ALHC) United States $2.764B 0.00
Concentras Parent (CON) United States $2.689B 15.54
Surgery Partners (SGRY) United States $2.589B 33.67
Organon (OGN) United States $2.548B 2.71
GeneDx Holdings (WGS) United States $2.274B 87.59
PACS (PACS) United States $1.943B 0.00
Ardent Health (ARDT) United States $1.851B 7.89
Premier (PINC) United States $1.802B 13.68
Progyny (PGNY) United States $1.782B 39.23
GoodRx Holdings (GDRX) United States $1.675B 33.50
Teladoc Health (TDOC) United States $1.384B 0.00
Pediatrix Medical (MD) United States $1.149B 8.74
Establishment Labs Holdings (ESTA) $1.058B 0.00
CareDx (CDNA) United States $1.055B 16.48
Ryman Healthcare (RYHTY) New Zealand $0.999B 0.00
Agilon Health (AGL) United States $0.890B 0.00
AMN Healthcare Services Inc (AMN) United States $0.811B 7.59
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
LifeMD (LFMD) United States $0.650B 0.00
Nutex Health (NUTX) United States $0.649B 9.83
Embecta (EMBC) United States $0.574B 3.87
InnovAge Holding (INNV) United States $0.536B 0.00
Enhabit (EHAB) United States $0.470B 38.67
Auna S.A (AUNA) Luxembourg $0.463B 10.42
Sonida Senior Living (SNDA) United States $0.457B 0.00
SBC Medicals (SBC) United States $0.450B 0.00
Omada Health (OMDA) $0.382B 0.00
Performant Healthcare (PHLT) United States $0.281B 0.00
Beauty Health (SKIN) United States $0.243B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.220B 0.00
Oncology Institute (TOI) United States $0.204B 0.00
DocGo (DCGO) United States $0.172B 28.17
So-Young (SY) China $0.168B 0.00
Pheton Holdings (PTHL) China $0.130B 0.00
OncoCyte (IMDX) United States $0.105B 0.00
KindlyMD (NAKA) United States $0.098B 0.00
Sera Prognostics (SERA) United States $0.070B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.051B 0.00
ModivCare (MODV) United States $0.049B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
Biodesix (BDSX) United States $0.039B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
SeaStar Medical Holding (ICU) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00